The 30-year-old reality TV star Kim Kardashian was diagnosed Sunday with the autoimmune disorder psoriasis, a skin disease that roughly affects 7.5 million Americans.
IBT Staff Reporter
Jul 26, 2011
So far, there have been 97 reported cases of illness resulting from an outbreak of Salmonella Agona, ten of which involved individuals being hospitalized, the U.S. Food and Drug Administration said.
IBT Staff Reporter
Jul 25, 2011
U.S. health regulators on Monday warned people not to eat Mexican-grown papayas from Texas distributor Agromod Produce Inc., as they investigate a possible link to a salmonella outbreak in 23 states. So far, the outbreak of Salmonella Agona has resulted in 97 reported cases of illness, ten of which involved individuals being hospitalized, across the country, the U.S. Food and Drug Administration said.
IBT Staff Reporter
Jul 25, 2011
Health officials say gonorrhea is showing resistance to the antibiotics used to treat it, causing concerns over a gonorrhea superbug outbreak. The resistant gonorrhea strain has not be found in the United states, but CDC officials say there are signs it could happen.
David Magee
Jul 12, 2011
The top after-market NASDAQ Stock Market gainers are: PAETEC Holding, SIGA Technologies, MYR Group, Zalicus, and Maiden Holdings. The top after-market NASDAQ Stock Market losers are: DragonWave, Quidel, Abaxis, BJ's Restaurants, and Signature Bank.
Balasubramanyam Seshan
Jul 06, 2011
Johnson & Johnson has recalled a massive amount of the painkiller Tylenol. Here is a factsheet on all you need to know about the drug, its recall and the company:
IBT Staff Reporter
Jun 30, 2011
Yoga is a way of life for good living and for the benefit of the body. Yoga is the only way through which the body will be fit and fine without any trainer, without equipment and medicine.
Ankita Mehta
Jun 05, 2011
Think you're a good speller? Check out the words that stumped this year's contestants.
Jeremy White
Jun 02, 2011
RBC Capital Markets said Xoma Ltd. (NASDAQ: XOMA) continues to make steady albeit measured progress toward initiating a pivotal trial in Behcet’s disease, which could begin by year-end 2011, pending regulatory feedback.
Balasubramanyam Seshan
May 10, 2011
RBC Capital Markets expects Vertex Pharmaceuticals Inc.'s (NASDAQ: VRTX) Incivek (telaprevir) to treat hepatitis C is likely to be approved on or around May 23.
Balasubramanyam Seshan
May 04, 2011
The top pre-market NASDAQ Stock Market gainers are: Varian Semiconductor Equipment Associates, Green Mountain Coffee Roasters, Axcelis Technologies, ValueClick, AXT, and Silicon Graphics International. The top pre-market NASDAQ Stock Market losers are: Key Tronic, Motricity, Kandi Technologies, First Solar, Century Aluminum, and Zalicus.
Balasubramanyam Seshan
May 04, 2011
Roche Holding AG's arthritis and cancer drug, Rituxan, received approval from the U.S. Food and Drug Administration (FDA) to treat two rare disorders that cause blood vessel inflammation.
IBT Staff Reporter
Apr 20, 2011
Roche Holding AG's rheumatoid arthritis drug Actemra received approval from the U.S. Food and Drug Administration (FDA) to treat a rare type of arthritis in children.
IBT Staff Reporter
Apr 19, 2011
The defending champion discusses the upcoming Masters tournament
Bobby Ilich
Apr 06, 2011
The slugger is in federal court on counts of perjury and obstruction of justice.
Bobby Ilich
Mar 24, 2011
Many doctors are doing little or nothing to help their overweight or obese patients to lose weight but many of them have made new year resolutions for weight loss, according to a new Harris Poll.
Balasubramanyam Seshan
Feb 22, 2011
Scientists have found a protein that acts as a master switch to determine whether certain white blood cells will boost or dampen inflammation, a finding that may help the search for new drugs for rheumatoid arthritis.
Joy Lee
Jan 17, 2011
Swiss pharma giant Roche said it plans to cut 4,800 jobs worldwide over the next two years due to mounting cost pressures in healthcare -particularly in the US and Europe - and increasing hurdles for the approval and pricing of new medicines.
Manikandan Raman
Nov 17, 2010